Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 507349, 6 pages
http://dx.doi.org/10.1155/2015/507349
Research Article

The Effect of Xuefuzhuyu Oral Liquid on Aspirin Resistance and Its Association with rs5911, rs5787, and rs3842788 Gene Polymorphisms

1Cardiovascular Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
2Physical Examination Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
3Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266033, China

Received 15 May 2015; Revised 3 August 2015; Accepted 11 August 2015

Academic Editor: Lay Kek Teh

Copyright © 2015 Mei Xue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Quality Inspection Report of Xuefuzhuyu Oral Liquid.

The main active components used for quality control in Xuefuzhuyu oral liquid (national medicine permit number Z10950063, batch number 1211010) are paeoniflorin (=1.4 mg/mL) and ferulic acid (=0.15 mg/mL), which meet the requirement of China State Food and Drug Administration (the state drug standards number YBZ11722004).

  1. Supplementary Materials